Login

Camino a la excelencia translates to "Pathway to excellence." 00:10:00

Share On Facebook Share On Twitter

Tomas Cordoba - CEO - MetroGAS

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
A2A highlights Andres Acebo and features a CEO spotlight on Priscilla Almodovar joining Fannie Mae as CEO.
00:10:00
helped over 600 companies turn their vision into reality|Ganesh Bell,Managing Director,Insight Partners
00:10:00
Leading LGBTQIA+/Allies investment syndicate that has invested $110M|Paul Grossinger,Founder,Gaingels
00:10:00
3U HOLDING AG - Annual review 2019 | Christoph Hellrung, CFO, 3U Holding AGUUUX:GER
00:10:00
Step into the world of DFNN with Chris Tiu and learn more about the IT company | Ramon C. Garcia Jr, CEO, DFNN IncDFNN:PHS
00:10:00
Addressing global challenges with societally-beneficial solutions|Dr Geoffrey Cumming,DIRECTOR,Anteo Diagnostics Ltd
00:10:00
Mark Henderson on Laramide Resources' Strategic Position in the Uranium Market
00:10:00
Fragmentos de Conversación y Reflexiones en Música
00:10:00
AVACTA's Chief Scientific Officer, Dr. Fiona McLaughlin | Alastair Smith, CEO, AVACTA THERAPEUTICS.
00:10:00
New Pacific Metals: Advancing Precious Metals Projects in Bolivia
00:10:00
German Junior Mining Company Expands Lithium Ventures in Argentina
00:10:00
Lucara Diamond Corporation: Market Update and Strategic Outlook

© 2017 - Neuhu+